Clinical application of a new pathophysiologic based device to titrate CPAP in patients with OSA

B. Schönhofer, J. Kerl, S. Suchi, D. Köhler (Schmallenberg, Germany)

Source: Annual Congress 2002 - Auto-CPAP in sleep apnoea: clinical aspects
Session: Auto-CPAP in sleep apnoea: clinical aspects
Session type: Oral Presentation
Number: 168
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Abstract

Rationale: Flow limitation is the pathophysiologic basis of OSA. We investigated SelfSet® (MAP, Martinsried, Germany), a CPAP device, which monitors airflow as a function of changing pressures to find the optimal CPAP.
Methods: 60 Patients with OSA were included. After a baseline polysomnographic recording (see table) a recording with the SelfSet® followed. The algorithm of the device antagonises flow limitation. Every 2 minutes a "miniset" manoeuvre is performed, i.e. CPAP increases by 2 H2O and afterwards decreases by 4 H2O. The airflow of 3 breaths before, during and after the miniset is measured by a pneumotachygraph. The minimum CPAP*, eliminating flow limitation, was determined. Finally in a split night 2 different constant CPAP levels were applied: In the 1. part the CPAP level* found by SelfSet®, in the 2. part additional 2 cm H2O CPAP to test whether SelfSet® underestimated the required pressure.
Results: See table (# p< 0.00001, baseline vs 1. part split night)

Baseline 1. part of split night 2. part of split night
CPAP [H2O] - 8.6 ±]2.0 10.6 ±]2.0
RDI [1/h] 61.3 ±]23.7 16.7 ±]11.0# 16.8 ±]11.4
Apnea Index [1/h] 31.7 ±]19.6 4.0 ±]5.8# 4.8 ±]7.4


Conclusion: The pathophysiologic based algorithm of the SelfSet® device proved to be a feasible means to find the optimal constant CPAP to treat OSA in the majority of patients.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Schönhofer, J. Kerl, S. Suchi, D. Köhler (Schmallenberg, Germany). Clinical application of a new pathophysiologic based device to titrate CPAP in patients with OSA. Eur Respir J 2002; 20: Suppl. 38, 168

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of OSA treatment with a new auto-CPAP mode
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

CPAP setting prediction in OSAS patients
Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Year: 2011

Pressure changes after CPAP titration in OSAS patients with poor clinical response to mathematic adjustment
Source: Annual Congress 2007 - Nursing interventions in the prevention and management of respiratory disease
Year: 2007


Multidisciplinary evaluation can find effective alternative treatment to CPAP in OSA patients
Source: International Congress 2017 – Diagnostic approaches to obstructive sleep apnoea
Year: 2017

Alternative method for non-invasive automatic positive airway pressure therapy in OSAS patients
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011

Nasal CPAP in the therapy of OSAS – does a closer patient guidance and support increase compliance?
Source: Eur Respir J 2005; 26: Suppl. 49, 707s
Year: 2005

Current automatic CPAP devices exhibit different response when tested with an improved simulator of OSA patient
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015

CPAP telemonitoring and residual AHI: Clinical cases and impact for follow-up management
Source: Sleep and Breathing Conference 2021
Year: 2021


The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Effect of auto-CPAP therapy on parameters of rhinomanometry in patients with COPD combined with OSAHS
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Implementation of continuous positive airway pressure treatment in patients with obstructive sleep apnoea-hypopnoea syndrome by the self titration method with auto-adjusting CPAP at home. Experience in the real life
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

The place of CPAP in the current guidelines for OSAS treatment in children
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017

Improved adherence with PAP therapy after switching from CPAP to bilevel for non-compliant OSA patients
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018




Is the daytime CPAP titration effective for determining therapeutic pressure levels in OSA patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 417s
Year: 2001

Clinical implications of residual sleep apnoea after chronic CPAP therapy
Source: Breathe 2011; 7: 289-290
Year: 2011

Is there an optimal CPAP mode for OSAS?
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017

Automatic CPAP titration with different self-setting devices in patients with obstructive sleep apnoea
Source: Eur Respir J 2004; 24: 273-278
Year: 2004



Improvement of machine compliance when switching patients with OSA to C-flex
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


A new UK approach in the management of patients on continuous positive airway pressure (CPAP) therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 96s
Year: 2003